Diabetes in Japan: The Markets for Monitoring, Insulin, Oral Hypoglycemics, and Drugs to Treat Complications

   Single User - $371
   Corporate License - $742

Published Apr 1, 2003 | 26 Pages | Pub ID: KLI862454

Special Offer. Now 25% off the original price of $495.
The market for diabetes care products covers the spectrum of clinical medicine, including diagnostics, biologics, and drugs. Several areas have strong growth potential and others, such as drugs to treat complications, represent large underserved markets for drugs primarily marketed to other populations. Segmentation of patient populations in novel ways, such as diabetic candidates for cardiovascular drugs, presents an excellent opportunity to expand markets and influence prescription practices in some markets.

Scope and Methodology

In addition to epidemiology of diabetes Type 1 and Type 2 in Japan, this market summary will examine the top line market numbers in each of the following segments in Japan, covering the period from 1999 and projected through 2007:

  • Monitoring—including glucose, ketone, and microalbumin;
  • Therapeutics—including insulin and oral hypoglycemics; and
  • Drugs to treat complications in the diabetic population—including antihypertensives, lipid-lowering drugs, antiarrhythmics, and peripheral vascular disease drugs.

Data for this report were primarily gathered through interviewing with industry participants and members of industry organizations, government, and the clinical medical profession. In addition, exhaustive searches of trade and clinical literature and market modeling based on epidemiology provided context and validation of market assumptions.



  • Diagnosed Diabetes Population In Japan, 1999-2007
  • Prevalence Rates for Diagnosed Type 1 and Type 2 Diabetes Mellitus In Japan, 1999-2007

Total Market

  • Total Market for Diabetes Products, Equipment, and Supplies In Japan, 1999-2007


  • Market for Blood Glucose Monitoring Equipment and Supplies In Japan 1999-2007

Diabetes Therapeutics

  • Market for Insulin In Japan, 1999-2007
  • Market for Oral Hypoglycemic Drugs in Japan, 1999-2007

Diabetic Complications

  • Market for Anti-Hypertensive Drugs for the Diabetic Population In Japan, 1999-2007
  • Market for Lipid-Lowering Drugs for the Diabetic Population In Japan, 1999-2007
  • Market for Anti-Arrhythmic Drugs for the Diabetic Population In Japan, 1999-2007
  • Market For Peripheral Vascular Disease Drugs for The Diabetic Population in Japan, 1999-2007

Major Competitors